Targeted DNA/RNA Sequencing Market Share, Growth, Trends, and Forecast, 2021-2031

The global Targeted DNA/RNA Sequencing market is experiencing robust growth, driven by continuous technological advancements and the availability of innovative and cost-effective sequencing platforms. This article provides a comprehensive analysis of the market’s evolution, key drivers, and current prospects, highlighting trends that are expected to shape the market from 2021 to 2031.

Get a Sample Copy of the Market Research Report (Use Corporate Mail Id for Quick Response) –https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=83683

Evolution of Targeted DNA/RNA Sequencing

Targeted sequencing, an efficient method for detecting known and novel variants in specific sets of genes or genomic regions, has gained prominence. This includes both DNA-based targeted sequencing and RNA-based targeted sequencing. These methods play a pivotal role in drug discovery, human biomedical research, and plant & animal sciences, offering accuracy and efficiency.

Key Drivers of Global Targeted DNA/RNA Sequencing Market

1. Technological Advancements:
   • Continuous technological advancements contribute to the growth of the market, enhancing the efficiency and accuracy of sequencing platforms.
2. Next-Generation Sequencing Methods:
   • The rise in the use of next-generation sequencing methods, such as exome sequencing and RNA-Seq, particularly in research and development, is a significant driver.
3. Launch of New Products:
   • Major players focus on launching new targeted DNA/RNA sequencing products, fostering market growth. The introduction of portfolios for translational and clinical applications further propels the market.

Market Segmentation

By Type:

1. DNA-based Targeted Sequencing:
   • Expected to lead the market due to its cost-effectiveness, time efficiency, and the availability of a range of products facilitating DNA sequencing.
2. RNA-based Targeted Sequencing:
   • Utilized for highly accurate selection and sequencing of specific transcripts, providing both quantitative and qualitative information.

By Application:

1. Drug Discovery:
   • Projected to dominate the market, with methods such as exome sequencing being commonly used and preferred in drug discovery.
2. Human Biomedical Research:
   • Plays a crucial role in advancing biomedical research, contributing to the understanding of genetic factors in diseases.
3. Plant & Animal Sciences:
   • Contributes to advancements in agriculture and animal sciences, aiding in the study of genetic variations.

By End-user:

1. Academic & Research Institutes:
   • Expected to witness strong growth due to increased research and development activities and the demand for targeted DNA/RNA sequencing.
2. Pharma & Biotech Companies:
   • Significant players in utilizing targeted sequencing for drug discovery and research purposes.

By Region:

1. North America:
   • Projected to dominate the market initially, driven by the presence of genome centers, major players, effective regulatory bodies, and technological advancements.
2. Asia Pacific:
   • Expected to witness high growth, attributed to increasing technical expertise and a rising focus on patient well-being.

Key Players

The global Targeted DNA/RNA Sequencing market is highly fragmented, with key players including Illumina, F. Hoffmann-La Roche Ltd., Agilent Technologies, Thermo Fisher Scientific, QIAGEN, Perkin Elmer, Bio-Rad Laboratories, GATC Biotech AG, DNASTAR, Integrated DNA Technologies, RainDance Technologies, and others.